Metabolic research
Cagrilintide
Investigational amylin analog in clinical trials. Not FDA-approved.
- Type
- Peptide
- Research area
- Metabolic research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About Cagrilintide
Investigational amylin analog in clinical trials. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
